InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference
MIAMI, March 31, 2026 -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Webb Campbell
Gilmartin Group LLC
[email protected]
[email protected]
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hartree Partners acquires USD 68,82 of Hudson Technologies shares
--Veralto Keeps Quarterly Dividend at $0.13 a Share, Payable Oct. 30 to Shareholders of Record on Sept. 30
Crypto prices
More
